These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12392879)

  • 1. Introduction to JMCC symposium on myocardial energy metabolism in health and disease.
    Lopaschuk GD; Opie LH
    J Mol Cell Cardiol; 2002 Sep; 34(9):1075-6. PubMed ID: 12392879
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in energy metabolism in cardiomyopathies.
    Taha M; Lopaschuk GD
    Ann Med; 2007; 39(8):594-607. PubMed ID: 17934906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action of etimizol on the energy metabolism of the neurogenically damaged myocardium].
    Novikov VP
    Biull Eksp Biol Med; 1981 Jun; 91(6):698-9. PubMed ID: 7272488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms of the changes in myocardial energy metabolism in pathology].
    Saks VA; Smirnov VN
    Kardiologiia; 1980 May; 20(5):10-2. PubMed ID: 7392371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac disfunction and myocardial energy metabolism caused by interleukin-2 (IL-2)].
    Takeuchi K; Takashima K; Tsushima T; Suzuki S; del Nido PJ
    Kyobu Geka; 1996 Apr; 49(4):278-80. PubMed ID: 8721357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Energy metabolism and myocardial ultrastructure in autoimmune cardiomyopathy].
    Popovich MI; Severin VV; Sharov VG
    Biull Eksp Biol Med; 1986 Dec; 102(12):671-4. PubMed ID: 3801617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of energy substrate metabolism in the diabetic heart.
    Stanley WC; Lopaschuk GD; McCormack JG
    Cardiovasc Res; 1997 Apr; 34(1):25-33. PubMed ID: 9217869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Arzni carbonate mineral baths on oxidative-reductive processes in the myocardium in focal metabolic damage (an experimental study)].
    Aladzhian AM; Movsesian TG; Aznaurian AV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):7-10. PubMed ID: 6226155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression of energy metabolism-related genes in myocardial tissues of rats with diabetic cardiomyopathy].
    Chen G; Lin LX; Zhuang WT; Yao J; Liang JX; Huang HB; Lin F; Lin JL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1009-10. PubMed ID: 12433633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical pharmacology of cardiac glycosides].
    Chekman IS
    Vestn Akad Med Nauk SSSR; 1982; (5):29-34. PubMed ID: 6285630
    [No Abstract]   [Full Text] [Related]  

  • 11. [Energy metabolism and myocardial function in myocardiodystrophy].
    Temirova KV; Kurlygina LA; Zavodskaia IS; Novikova NA
    Kardiologiia; 1976 Sep; 16(9):98-102. PubMed ID: 1011536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular basis of viable dysfunctional myocardium.
    Bayeva M; Sawicki KT; Butler J; Gheorghiade M; Ardehali H
    Circ Heart Fail; 2014 Jul; 7(4):680-91. PubMed ID: 25028350
    [No Abstract]   [Full Text] [Related]  

  • 13. The PPAR regulatory system in cardiac physiology and disease.
    Finck BN
    Cardiovasc Res; 2007 Jan; 73(2):269-77. PubMed ID: 17010956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular abnormalities in cardiomyopathy.
    Dhalla NS; Sulakhe PV; Fedelesova M; Yates JC
    Adv Cardiol; 1974; 13():282-300. PubMed ID: 4281275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on myocardial metabolism in patients with idiopathic cardiomyopathy].
    Dietze G; Wicklmayr M; Baubkus H; Müller-Seydlitz P; Gadomski M; Zeitlmann F; Rudolph W
    Verh Dtsch Ges Inn Med; 1969; 75():380-3. PubMed ID: 5400159
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac Metabolism in Perspective.
    Taegtmeyer H; Lam T; Davogustto G
    Compr Physiol; 2016 Sep; 6(4):1675-1699. PubMed ID: 27783856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism in cardiomyopathy: every substrate matters.
    Ritterhoff J; Tian R
    Cardiovasc Res; 2017 Mar; 113(4):411-421. PubMed ID: 28395011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine metabolism. Role in acute ischemia and chronic myocardial disease.
    Z Kardiol; 1987; 76 Suppl 5():1-58. PubMed ID: 3433880
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic therapy of cardiopathies, based on the biochemical physiopathology of the myocardium].
    Galeone A
    Ann Osp Maria Vittoria Torino; 1983; 26(7-12):235-92. PubMed ID: 6238564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats.
    Ménard SL; Croteau E; Sarrhini O; Gélinas R; Brassard P; Ouellet R; Bentourkia M; van Lier JE; Des Rosiers C; Lecomte R; Carpentier AC
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1049-57. PubMed ID: 20159856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.